Prevention guidelines for early-onset colorectal cancer

Overview of Early-onset Colorectal Cancer

The second most common cause of cancer-related fatalities and the third most common cancer globally is colorectal cancer. Usually, it begins as little polyps in the colon or rectum that, if left untreated, can develop into cancer. Early identification through screening significantly increases survival rates.

Colorectal Cancer: What Is It?

Definition: An unchecked proliferation of aberrant cells in the rectum or colon, two sections of the large intestine.
Origin: Usually starts out as benign polyps that, if neglected, can develop into cancer.
Global Burden: In 2022, it was responsible for over 900,000 deaths worldwide and around 10% of all cancer diagnoses.

Colorectal cancer

Symptoms

Alterations in bowel habits (constipation, diarrhoea, stool narrowing).
Stool containing blood (bright red or tar-like).
Bloating, cramping, or persistent stomach pain.
Weariness and inexplicable weight loss.
Chronic bleeding-related iron deficiency anaemia.

Screening and Diagnosis

Polyps are found and removed by colonoscopy and sigmoidoscopy.
Imaging: ultrasonography, CT, and MRI.
Biopsy: Verifies the type of malignancy.
Genetic testing: finds mutations that direct therapy.
Screening Programs: Frequent colonoscopies lower mortality and incidence.

Preventive

Consume a diet high in whole grains, fruits, and vegetables.
Limit alcohol and red and processed meats.
Keep up an active lifestyle and a healthy weight.
Don't smoke.
Get tested regularly after age 45 to 50, or earlier if you are at high risk.

Risk factors for colorectal cancer

Age (the majority of cases occur after 50), family history, inherited genetic disorders, inflammatory bowel disease, and lifestyle factors like alcoholism, smoking, obesity, and diets heavy in red and processed meats are the main risk factors for colorectal cancer. In India, screening and awareness are particularly crucial due to the increasing incidence among younger adults.

Important Risk Elements

Personal and Genetic History
Adenomatous polyps or colorectal cancer run in the family.
Inherited syndromes include Lynch syndrome (HNPCC) and familial adenomatous polyposis (FAP).
Recurrence risk is increased by a personal history of colorectal cancer or polyps.
Inflammatory bowel diseases include Crohn's and ulcerative colitis.
radiation exposure to the pelvis and abdomen during previous cancer treatments.

Lifestyle Elements

Diet: poor in fruits and vegetables, high in red and processed meats, and poor in vitamin D.
Men are more strongly linked to obesity, which is likewise linked to negative outcomes.
Physical inactivity: Living a sedentary lifestyle increases the risk.
Smoking: Long-term tobacco use raises the risk of cancer and polyps.
Alcohol: Higher risk is associated with moderate to excessive consumption.

Health Issues

Insulin resistance increases the likelihood of developing type 2 diabetes.
Cholecystectomy (gallbladder removal): There is a slightly increased risk of right-sided colon cancer.

Factors related to demographics

Age: People over 45 account for 93% of cases.
Sex: Women are more likely to acquire right-sided colon cancer after menopause, but men have a greater fatality rate.
Ethnicity: International research indicates that American Indians, African Americans, and Ashkenazi Jews are more vulnerable.

Screening techniques for colorectal cancer

For average-risk individuals, colorectal cancer screening should begin at age 45; for those with a family history or genetic disorders, it should begin earlier. Although stool-based tests (FIT, gFOBT, stool DNA) and imaging methods (CT colonography, sigmoidoscopy) are also commonly employed, a colonoscopy every ten years is the most effective test.

Principal Screening Techniques

Tests Based on Stools
The guaiac fecal occult blood test (gFOBT) involves dietary restrictions in order to detect concealed blood in stool. completed once a year.
Faecal immunochemical test (FIT): No dietary limitations; uses antibodies to detect blood. completed once a year.
FIT-DNA (sDNA-FIT, such as Cologuard): Identifies DNA mutations in feces and blood. carried out every three years.

Tests of Direct Visualization

Polyps may be removed via a colonoscopy, which examines the whole colon. Every ten years is recommended.
Flexible sigmoidoscopy: Examines the lower colon and rectum. completed every five years or, with annual FIT, every ten years.
CT colonography, also known as virtual colonoscopy, uses CT imaging to view the colon. carried out every five years.

Rules

Adults at average risk: Begin at age 45.
High-risk conditions (IBD, FAP, Lynch syndrome, family history): Screen more frequently and begin earlier (usually between the ages of 20 and 40).
Ages 76–85: Depending on health status, screening is customized.

Early signs of colorectal cancer

Regular screening is essential since early signs of colorectal cancer are frequently mild or nonexistent. They can include anaemia-related fatigue, blood in the stool, abdominal pain, chronic changes in bowel habits, and unexplained weight loss. Awareness is particularly crucial due to an increase in instances among younger individuals.

Typical Early Symptoms

Constipation, diarrhea, or narrowing of the stool that lasts more than a few days are examples of changes in bowel habits.
Stools that include blood might be bright red, dark brown, or black. It's essential to pay attention to even the smallest amounts.
The feeling that the bowel does not empty after a movement is known as incomplete bowel emptying.
Persistent fullness, bloating, or pain are examples of abdominal pain or cramps.
Losing weight without dieting or altering one's lifestyle is known as "unexplained weight loss."
Weakness and exhaustion: Frequently brought on by concealed blood loss that results in iron-deficiency anemia.

The Significance of Early Detection

Screening is the most effective preventive measure because polyps and early malignancies frequently have no symptoms.
When doctors discover colorectal cancer early, survival rates exceed 90%, but they drop sharply once the cancer spreads.
Since late-stage diagnosis is typical, it's critical to spot minor symptoms and schedule an appointment for a colonoscopy or FIT tests as soon as possible.

The video explains how to prevent colorectal cancer

Techniques for treating colorectal cancer

Treatment plans for colorectal cancer are based on the patient's health, the tumour's location (colon vs. rectum), and its stage. While chemotherapy, radiation, targeted therapy, or immunotherapy frequently help manage advanced stages of the disease, surgery remains the mainstay for early stages. While late-stage therapy concentrates on control and quality of life, early identification enables curative treatment.

Treatment Strategies Based on Stages

Main Treatment Notes for Stage

Stage 0 (in situ): Local excision or polypectomy. Usually curative; no additional treatment is required.
Stage I: Surgery (proctectomy/colectomy). Frequently curative; adjuvant treatment is not necessary.
Stage II: Chemotherapy ± Surgery Rectum: radiation and chemotherapy before and following surgery; colon: chemotherapy in high-risk situations.
Stage III: Chemotherapy and surgery. Chemotherapy and radiation are used before and after surgery for rectal cancer.
Stage IV: Chemotherapy, targeted therapy, immunotherapy, and surgery. Palliative care is used to relieve symptoms; surgery may be used to remove lung or liver metastases.

Methods of Treatment

Surgery
primary treatment choice.
Types include abdominoperineal resection, colectomy, proctectomy, and polypectomy.
Colostomy may be necessary in cases of rectal cancer.

Chemotherapy

Medications such as irinotecan, oxaliplatin, capecitabine, and 5-FU.
Used as a neoadjuvant (before to surgery) or adjuvant (after surgery).

Radiation treatment

It is more typical in cases of rectal cancer.
Reduces tumor size before surgery or eliminates any remaining cells after surgery.

Targeted treatment for KRAS/NRAS wild-type cancers with EGFR inhibitors (cetuximab, panitumumab).

Bevacizumab, a VEGF inhibitor, is used to treat metastatic illness.

Immunotherapy

Pembrolizumab and nivolumab are checkpoint inhibitors for MSI-H/dMMR cancers.
Efficient in situations that are advanced or recurrent.

Treatment-related risks and considerations

Infection, bleeding, and gastrointestinal dysfunction are risks associated with surgery.
Chemotherapy side effects include tiredness, neuropathy, and nausea.
Radiation: May result in sexual dysfunction and intestinal discomfort.
Immunotherapy and targeted therapy may cause immunological adverse effects.

Conclusion

Although colorectal cancer is one of the most treatable and preventable tumors when caught early, it is nevertheless a significant worldwide health concern. Before becoming malignant, the disease usually starts as benign polyps that doctors can remove. Age, lifestyle choices, and heredity are risk factors. Screening techniques like colonoscopy or stool-based testing are crucial for prompt detection because early symptoms are frequently vague.

In conclusion, early detection and aggressive prevention are critical to the prognosis of colorectal cancer. The best strategy to lower risk and increase survival is to adopt healthy habits and talk to a gastroenterologist about timely screening.